Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de David Veitch
Age : 57
Public asset : 64,354 USD
Linked companies : Basilea Pharmaceutica AG
Summary 
David Veitch is Chief Executive Officer for Basilea Pharmaceutica AG.

In his past career he occupied the position of President-European Operations at Savient Pharmaceuticals, Inc. and SVP-European Marketing & Brand Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd.

He received an undergraduate degree from the University of Bristol.


Current positions of David Veitch 
NameTitle Since
Basilea Pharmaceutica AG
(Biotechnology & Medical Research)
Chief Executive Officer 2018


Holdings of David Veitch 
NameEquities%Valuation
Basilea Pharmaceutica AG (BSLN)
(Biotechnology & Medical Research)
1,3000.0099%64,354 USD


David Veitch: Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/26LVMH's Arnault brushes off succession question
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
02/02Billionaire Cohen builds stake in Nordstrom, urges board shakeup
RE
02/03Exclusive-BlackRock sustainability chief Bodnar to join Bezos Earth Fund - memo
RE
02/03U.S. jury finds Tesla and Musk not liable in case over take-private tweet
RE
02/03SoftBank Q3 seen under pressure from tech weakness, Arm IPO eyed
RE
02/07U.S. says associate of Russian oligarch Vekselberg charged over sanctions evasion
RE
02/01Sony Group CFO Totoki to succeed Yoshida as president - Nikkei
RE
More news


© 2023 People and Ownership :   
David Veitch : Connections